Cargando…

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells

The oncolytic rodent protoparvoviruses (PVs) minute virus of mice (MVMp) and H-1 parvovirus (H-1PV) are promising cancer viro-immunotherapy candidates capable of both exhibiting direct oncolytic activities and inducing anticancer immune responses (AIRs). Type-I interferon (IFN) production is instrum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelova, Assia, Pierrard, Kristina, Detje, Claudia N., Santiago, Estelle, Grewenig, Annabel, Nüesch, Jürg P. F., Kalinke, Ulrich, Ungerechts, Guy, Rommelaere, Jean, Daeffler, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144674/ https://www.ncbi.nlm.nih.gov/pubmed/37111493 http://dx.doi.org/10.3390/pathogens12040607

Ejemplares similares

Immune System Stimulation by Oncolytic Rodent Protoparvoviruses
por: Angelova, Assia, et al.
Publicado: (2019)

Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study
por: Marchini, Antonio, et al.
Publicado: (2019)

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients
por: Angelova, Assia L., et al.
Publicado: (2015)

Vesicular Egress of Non-Enveloped Lytic Parvoviruses Depends on Gelsolin Functioning
por: Bär, Séverine, et al.
Publicado: (2008)

Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro
por: Geiss, Carsten, et al.
Publicado: (2017)

Oncolytic parvoviruses: from basic virology to clinical applications
por: Marchini, Antonio, et al.
Publicado: (2015)

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers
por: Angelova, Assia L., et al.
Publicado: (2017)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
por: Angelova, Assia L., et al.
Publicado: (2017)

Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo
por: Lacroix, Jeannine, et al.
Publicado: (2018)

Human Protoparvoviruses
por: Väisänen, Elina, et al.
Publicado: (2017)

TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells
por: Raykov, Zahari, et al.
Publicado: (2013)

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
por: Ungerechts, Guy, et al.
Publicado: (2016)

Protoparvovirus Cell Entry
por: Ros, Carlos, et al.
Publicado: (2017)

Stability and safety key factors of the oncolytic protoparvovirus H-1 from manufacturing to human application
por: Frehtman, Veronika, et al.
Publicado: (2023)

Upstream process optimization and micro- and macrocarrier screening for large-scale production of the oncolytic H-1 protoparvovirus
por: Wohlfarth, Daniel, et al.
Publicado: (2021)

Viruses utilize ubiquitination systems to escape TLR/RLR-mediated innate immunity
por: Huang, Shanzhi, et al.
Publicado: (2022)

Protoparvovirus Knocking at the Nuclear Door
por: Mäntylä, Elina, et al.
Publicado: (2017)

Global Distribution of Human Protoparvoviruses
por: Väisänen, Elina, et al.
Publicado: (2018)

Pancreatic Cancer Cell Lines Can Induce Prostaglandin E2 Production from Human Blood Mononuclear Cells
por: Grekova, Svitlana P., et al.
Publicado: (2011)

RO 90-7501 Enhances TLR3 and RLR Agonist Induced Antiviral Response
por: Guo, Fang, et al.
Publicado: (2012)

Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections
por: Tessmer, Claudia, et al.
Publicado: (2022)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Epidemiology of two human protoparvoviruses, bufavirus and tusavirus
por: Väisänen, Elina, et al.
Publicado: (2016)

Protoparvovirus Interactions with the Cellular DNA Damage Response
por: Majumder, Kinjal, et al.
Publicado: (2017)

Crosstalk between Autophagy and RLR Signaling
por: Ke, Po-Yuan
Publicado: (2023)

Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers
por: Angelova, Assia, et al.
Publicado: (2021)

ZNF205 positively regulates RLR antiviral signaling by targeting RIG-I: ZNF205 regulates RLR antiviral signaling
por: Zhong, Ni, et al.
Publicado: (2023)

Vesicular Transport of Progeny Parvovirus Particles through ER and Golgi Regulates Maturation and Cytolysis
por: Bär, Séverine, et al.
Publicado: (2013)

PKCη/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis
por: Bär, Séverine, et al.
Publicado: (2015)

Structural Characterization of Cuta- and Tusavirus: Insight into Protoparvoviruses Capsid Morphology
por: Mietzsch, Mario, et al.
Publicado: (2020)

Detection at high prevalence of newlavirus (protoparvovirus) in the carcasses of red foxes
por: Lanave, Gianvito, et al.
Publicado: (2022)

Activation and Evasion of RLR Signaling by DNA Virus Infection
por: Jia, Junli, et al.
Publicado: (2021)

Emerging role of Natural killer cells in oncolytic virotherapy
por: Bhat, Rauf, et al.
Publicado: (2015)

Molecular characterization of carnivore protoparvovirus 1 circulating in domestic carnivores in Egypt
por: Ndiana, Linda A., et al.
Publicado: (2022)

Mutations in the Non-Structural Protein-Coding Sequence of Protoparvovirus H-1PV Enhance the Fitness of the Virus and Show Key Benefits Regarding the Transduction Efficiency of Derived Vectors
por: Hashemi, Hamidreza, et al.
Publicado: (2018)

Mitochondrial Protein PINK1 Positively Regulates RLR Signaling
por: Zhou, Jun, et al.
Publicado: (2019)

Molecular Characterization and Evolutionary Analyses of Carnivore Protoparvovirus 1 NS1 Gene
por: Mira, Francesco, et al.
Publicado: (2019)

Identification of DreI as an Antiviral Factor Regulated by RLR Signaling Pathway
por: Li, Shun, et al.
Publicado: (2012)

Transcriptional analysis of antiviral small molecule therapeutics as agonists of the RLR pathway
por: Green, R.R., et al.
Publicado: (2016)

RLR-mediated antiviral innate immunity requires oxidative phosphorylation activity
por: Yoshizumi, Takuma, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9bppqo15mk73852a736e30e2aa